Elizabeth Pearce, MD
Otolaryngology · Falmouth, MENPI 1720221401
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,713 of the $5,076 with a category attached, or 73.2%. 7 manufacturers reported payments, led by Aerin Medical Inc. at 56.0% of the total. Reporting peaked in 2024 at $4,004 and has fallen 98.4% since, to $64 in 2025. Among otolaryngology clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $149.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$3K
- Smith+Nephew$1K
- Stryker$959
- Integra Lifesciences Corporation$81
- Regeneron Healthcare Solutions, Inc.$24
- Alk-abello, Inc$22
- plus $20 from 1 others
What the payments were for
- Travel & lodging$3,71373%
- Food & beverage$1,36227%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 14 | $2,840 |
| Smith+Nephew | 6 | $1,129 |
| Stryker | 7 | $959 |
| Integra Lifesciences Corporation | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Alk-abello, Inc | 1 | $22 |
| Merck | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$2,418
- Coblation$1,002
- TULA$1,002
- SCOPIS ENT$592
- XPRESS ENT DILATION SYSTEM$270
How this compares
$5,076 in reported general payments places this provider in the 90th percentile of 42 otolaryngology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 19 | $594 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $128 |
| Sertraline Hcl | 17 | $120 |
| Prednisone | 14 | $24 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Falmouth
- Jeffrey BedrosianPortland$727K
- Peter O'ConnorBrunswick$27K
- Stephen MaturoPortland$14K
- William ReedScarborough$4K
- Brian CusickAugusta$4K
- Rebecca HarveyScarborough$4K
- Jay RaisenScarborough$4K
- Nicholas AndresenAugusta$2K
- Christopher SarnoKittery$2K
- Debra GonzalezAugusta$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.